Author

Nina A. Cantafio

Observed name: Nina Cantafio

Observed institutions: Translational Genomics Research Institute, Tower Cancer Research Foundation, Mayo Clinic in Arizona, University of Arizona Cancer Center, Translational Drug Development (United States)

OpenAlex ID: A5069493728

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

2010 · Daniel D. Von Hoff, Joseph J. Stephenson, et al. · Journal of Clinical Oncology · 650

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

2014 · Gayle S. Jameson, Emanuel F. Petricoin, et al. · Breast Cancer Research and Treatment · 81

A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer.

2013 · Gayle S. Jameson, Emanuel Petricoin, et al. · Journal of Clinical Oncology · 6

Abstract B24: Gastrointestinal microbiome changes in stage IV pancreatic cancer patients treated with pembrolizumab with or without paricalcitol on the Stand Up to Cancer (SU2C) Pancreas Catalyst Trial

2019 · Sarah K. Highlander, Vincent Chung, et al. · Cancer Research · 1

Abstract #LB-259: A pilot study utilizing molecular profiling of patients\#8217; tumors to find potential targets and select treatments for their refractory cancers

2009 · Daniel D. Von Hoff, Joseph Stephenson, et al. · Cancer Research

Works count: 5

Citation count: 738

H-index: 3

I10-index: 2